Climate Change Data

Environmental Metrics

ESG Focus Areas

• Sustainable Development Goals (SDGs)

Social Achievements

• Launched Master in Life Science Venturing Innovation in collaboration with Campus Bio-Medico University and Marzotto Venture Accelerator

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Awards & Recognition

• Shortlisted for Prix Galien USA “Incubators, Accelerators, Equity” category
• CEO Italian Awards 2023 in the Life Science category

Environmental Metrics

ESG Focus Areas

• Environmental
• Social
• Governance

Social Achievements

• No work-related accidents or occupational illnesses reported in 2022.
• Implemented measures to contain the spread of COVID-19, including smart working.
• Hired a senior Head of HR starting September 2023.
• Received the Le Fonti Award for Excellence of the Year in Innovation as a Venture Builder in Life Science for the third time in July 2023.
• Selected as a finalist for the Galien Prix in New York in the fall of 2023.

Governance Achievements

• Successfully completed the IPO process on Euronext Growth Milan in March 2023.

Climate Goals & Targets

Environmental Challenges

• Reduction in operating profitability.
• Increase in financial expenses.
• Need to adapt organizational structures to manage the acceleration process triggered after the IPO.
• Uncertainty in the short-term economic forecasts.
• High probability of a significant worsening of profitability and financial results due to the immaturity of the portfolio companies.
• Significant financial resources required for the development of the portfolio companies.
• Potential for long development times or failure to reach the market for technologies/products.

Mitigation Strategies

• Successfully completed an IPO raising €4.105.000 in March 2023.
• Further capital increase of €500,000 in July 2023.
• New credit line of €500,000 in the process of finalization.
• Ongoing discussions with investors for an additional capital increase of €8 million.
• Discussions with IPO investors holding warrants potentially interested in exercising their conversion rights.
• Successful crowdfunding campaign for Biodiapers (€201,000) and co-financing for Adamas Biotech (€470,000) in 2022.
• Continued support from partner credit institutions, including a €1 million investment from Banca Progetto SpA and a €500,000 line of credit from Istituto San Paolo in 2022.
• Successful acquisition of SIMEST grants for Poland and Switzerland markets (€100,000 per program).
• Selection of R&D projects for new startups in July 2023.
• Development partnerships with IBI Lorenzini, Salix, and SICAM.
• MoU for Indian market development with Gujar Mal Modi Science Foundation.
• Planning for a Strategic Advisory Board meeting by December 2023.
• Maintaining an agile work structure and implementing precautionary measures to mitigate COVID-19 impacts.
• Hiring of a senior HR figure.

Supply Chain Management

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

• Biodiapers' technology for environmentally friendly absorbent products.

Awards & Recognition

• Le Fonti Award for Excellence of the Year in Innovation as a Venture Builder in Life Science (July 2023)

Environmental Metrics

ESG Focus Areas

• Democratization of Life Sciences
• Accessibility
• Sustainability
• Ethical Funding
• UN Sustainable Development Goals

Environmental Achievements

• Not disclosed

Social Achievements

• Promoting innovation and supporting the spin-off ecosystem in alignment with the United Nations’ 2030 Agenda for Sustainable Development Goals.
• Committed to reducing inequalities and improving access to healthcare technology.
• Fosters global partnerships to advance healthcare technology.

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Balancing primary vs. emerging markets for healthcare solutions.
• Bridging the gap between science and the market.

Mitigation Strategies

• Developing new models and partnerships to speed up the translation of scientific discoveries into market-ready solutions.
• Partnering with investors who share our values.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: UN SDGs

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Goal 3
• Goal 8
• Goal 9
• Goal 10

Cube Labs' activities contribute to these goals through innovation in healthcare technology, sustainable economic growth, industrial modernization, and reducing inequalities in access to healthcare.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed